Phexxi™ (lactic acid/citric acid/potassium bitartrate) – New drug approval
May 22, 2020 - Evofem announced the FDA approval of Phexxi (lactic acid/citric acid/potassium bitartrate), for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
Download PDF
